All In Biotech

Drug Trial Radar · NCT06099873

Study to Assess the Safety and Efficacy of ZX-7101A in Adolescents With Influenza

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Trial of ZX-7101A Tablets to Evaluate the Efficacy and Safety in the Treatment of Uncomplicated Influenza in Adolescents

Last checked: Nov 20, 2026Latest source record: Feb 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 361 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

361

Actual

Start

Nov 30, 2023

Primary completion

Feb 13, 2025

Study completion Feb 13, 2025

Sponsor

Sponsor type
Industry
First posted
Oct 25, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 12 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary object of this study is evaluating the efficacy of ZX-7101A tablets versus placebo in the treatment of uncomplicated simple influenza in adolescents. The seongdary object is evaluating the safety of ZX-7101A tablet in the treatment of uncomplicated simple influenza in adolescents.

Conditions

  • Respiratory Viral Infection

Interventions

  • ZX-7101ADrug

    Day1 Take one tablet of ZX-7101A orally once (specification: 40mg/ tablet) with appropriate amount of warm water

  • PlaceboDrug

    Day1 Take one tablet of Placebo orally once with appropriate amount of warm water

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The time to the remission of all influenza symptoms (hours)Time frame: From accepting ZX-7101A until the 15 days after the first dosing

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Fudan University affiliated Huashan Hospital

    Shanghai, Shanghai Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.